OHSU

Daniel L. Marks, M.D., Ph.D.

Head Shot of Daniel Marks
Email: 
click here
Office: 
503 346-0640

Lab Page: Click here

PubMed Listing: Click here


Background


Selected Publications

"A role for orexin in cytotoxic chemotherapy-induced fatigue," Brain, Behavior, and Immunity (Vol: 37, Page 84-94) - 2014

"Mechanism of protection by soluble epoxide hydrolase inhibition in type 2 diabetic stroke," PLoS ONE (Vol: 9, Issue: 5, ) - 2014

"Adipose tissue NK cells manifest an activated phenotype in human obesity," Metabolism: Clinical and Experimental (Vol: 62, Issue: 11, Page 1557-1561) - 2013

"Cancer- and endotoxin-induced cachexia require intact glucocorticoid signaling in skeletal muscle," FASEB Journal (Vol: 27, Issue: 9, Page 3572-3582) - 2013

"Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques," Diabetes (Vol: 62, Issue: 2, Page 490-497) - 2013

 

OHSU Doernbecher Children's Hospital

Visit Our Site

For Healthcare Professionals


Contact

  Email Daniel Marks

503 346-0640

Memberships & Associations

Oregon State Medical Society
American Medical Association